Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
about
Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1.Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice.Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells.Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling.Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells.
P2860
Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
@en
Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
@nl
type
label
Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
@en
Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
@nl
prefLabel
Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
@en
Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
@nl
P2093
P2860
P356
P1433
P1476
Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors
@en
P2093
Ameya R Kirtane
Fekadu Kassie
Jayanth Panyam
Jung Min Song
Kwon Ho Hong
Pramod Upadhyaya
P2860
P304
57752-57769
P356
10.18632/ONCOTARGET.10759
P407
P577
2016-09-01T00:00:00Z